Health Care & Life Sciences » Pharmaceuticals | Piramal Enterprises Ltd.

Piramal Enterprises Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
44,715
50,993
63,415
85,037
106,310
Cost of Goods Sold (COGS) incl. D&A
28,674
31,785
35,660
39,496
43,879
Gross Income
16,042
19,208
27,755
45,540
62,431
SG&A Expense
11,256
12,253
12,366
13,101
14,456
EBIT
3,740
5,996
-
-
47,302
Unusual Expense
4
3,193
353
100
34
Non Operating Income/Expense
472
31,493
1,732
849
584
Interest Expense
8,713
5,106
9,591
20,310
29,783
Pretax Income
4,348
30,354
7,600
13,103
19,638
Income Tax
628
3,450
495
2,281
28,764
Equity in Affiliates
31
1,593
1,942
1,699
2,801
Consolidated Net Income
5,007
28,497
9,047
12,520
51,203
Net Income
5,014
28,500
9,047
12,523
51,215
Net Income After Extraordinaries
5,014
28,500
9,047
12,523
51,215
Net Income Available to Common
5,014
28,500
9,047
12,523
51,215
EPS (Basic)
28.93
164.24
52.13
71.85
281.76
Basic Shares Outstanding
174
174
174
174
182
EPS (Diluted)
28.89
164.19
52.12
71.85
281.68
Diluted Shares Outstanding
174
174
174
174
182
EBITDA
6,209
8,894
17,321
35,482
52,075
Other Operating Expense
1,046
959
623
774
674
Non-Operating Interest Income
149
1,165
1,045
998
1,569
Minority Interest Expense
8
3
-
3
12

About Piramal Enterprises

View Profile
Address
Piramal Ananta
Mumbai Maharashtra 400070
India
Employees -
Website http://www.piramal.com
Updated 09/14/2018
Piramal Enterprises Ltd. engages in the business of pharmaceuticals and provision of financial services. It operates through the following segments: Pharmaceuticals Manufacturing and Services, Financial Services, and Healthcare Insights and Analytics. The Pharmaceuticals Manufacturing and Services segment operates through the following divisions: Pharma Solutions, Critical Care, Consumer Products Services and Imaging.